Bard1 Life Sciences (BD1) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXEXO-OC Study Outcome Investor Webinar Presentation
other announcement
Quarterly Activities Report and Appendix 4C - June 2026
other announcement
Investor Briefing on EXO-OC Test and study outcome
other announcement
Change of Director's Interest Notice - Peter Gunzburg
director_dealing announcement
Change of Director's Interest Notice - Peter Gunzburg
director_dealing announcement
Change of Director's Interest Notice - Peter Gunzburg
director_dealing announcement
Quarterly Activities Report and Appendix 4C - March 2026
other announcement
Change of Director's Interest Notice - Max Johnston
director_dealing announcement
Change of Director's Interest Notice - Mary Harney
director_dealing announcement
Change of Director's Interest Notice - Peter Gunzburg
director_dealing announcement
Change of Director's Interest Notice - Peter Gunzburg
director_dealing announcement
Change of Director's Interest Notice - Peter Gunzburg
director_dealing announcement
Quarterly Business Update and Appendix 4C - December 2025
other announcement
Notification regarding unquoted securities - IIQ
other announcement
Quarterly Business Update and Appendix 4C - September 2025
other announcement
IIQ completes placement and lodges SPP Offer Booklet
capital_raise announcement
IIQ Licences worldwide OC Biomarker IP from UniQuest
other announcement
CAR-NK EVs kill Breast Cancer Cells in vitro at Peter Mac
other announcement
Quarterly Business Update and Appendix 4C - June 2025
other announcement
New treatment kills 88% of Breast and Lung Cancer cells
other announcement